August 7, 2018 by Dale Yuzuki
Choosing between multiplex PCR enrichment methods? A few reasons to look at alternatives to AmpliSeq. If you turn back the clock to late 2011, it was an exciting time for [more]
July 23, 2018 by Dale Yuzuki
At 18% growth compounded annually, you’ll need to double your productivity every four years Market research is a strange animal. This industry depends upon the opinion of those they follow [more]
June 21, 2018 by Dale Yuzuki
Overlapping multiplex PCR gives single-well simplicity and outstanding data quality Introduction There is an ongoing need for the clinical laboratory operations to be made more streamlined, simplified and economical. With [more]
May 24, 2018 by Dale Yuzuki
The universe of cancer research is so large and so wide-ranging that attending a conference like the recent American Association for Cancer Research (#AACR18) in Chicago you may discover rising [more]
April 24, 2018 by Dale Yuzuki
American Association for Cancer Research 2018 Lung & Colon Cancer Panel in a CRC Cohort Poster Interview with Dr. Jianfeng Xiao At the recent American Association for Cancer Research (#AACR18), [more]
April 11, 2018 by Dale Yuzuki
At the recent Association for Molecular Pathology conference in Salt Lake City, Utah, we had the opportunity to ask Dr. Gang Song, Chief Executive Officer of Pillar Biosciences to talk [more]
March 27, 2018 by Dale Yuzuki
The complexity of the NGS process, compounded by sample processing, results in unique challenges for the clinical oncology laboratory Analysis of clinical samples for matching patients to targeted therapy is [more]
March 9, 2018 by Dale Yuzuki
The clinical oncology laboratory faces a challenge in implementing new technology, and with the advent of next-generation sequencing, that level of complexity has expanded on both the wet-laboratory side as well as the data-processing side.
February 26, 2018 by Dale Yuzuki
You are a clinical laboratory director responsible for the operations of a modern molecular pathology laboratory. This includes using next-generation sequencing as a laboratory-developed test to characterize individual patient samples to tailor individual treatment. Your work and profession have immediate impact on improving health, and you have adjusted to the increasingly rapid changes in molecular diagnostics.